688050 爱博医疗
已收盘 02-03 15:00:00
资讯
新帖
简况
10亿跨界并购背后：爱博医疗的增长焦虑与整合难题
新浪证券 · 01-22
10亿跨界并购背后：爱博医疗的增长焦虑与整合难题
爱博医疗(688050.SH)拟收购德美医疗不低于51%股权 拓宽医疗健康领域布局
智通财经 · 01-20
爱博医疗(688050.SH)拟收购德美医疗不低于51%股权 拓宽医疗健康领域布局
每周股票复盘：爱博医疗（688050）将召开2025年Q3业绩说明会
证券之星 · 2025-11-23
每周股票复盘：爱博医疗（688050）将召开2025年Q3业绩说明会
爱博医疗（688050）359.36万股限售股将于11月12日解禁，占总股本1.86%
证券之星 · 2025-11-12
爱博医疗（688050）359.36万股限售股将于11月12日解禁，占总股本1.86%
爱博医疗目标价涨幅超70%，荣盛石化、珀莱雅评级被调低
21世纪经济报道 · 2025-11-05
爱博医疗目标价涨幅超70%，荣盛石化、珀莱雅评级被调低
【机构调研记录】格林基金调研潮宏基、爱博医疗等3只个股（附名单）
证券之星 · 2025-11-05
【机构调研记录】格林基金调研潮宏基、爱博医疗等3只个股（附名单）
【机构调研记录】德邦基金调研爱博医疗
证券之星 · 2025-11-05
【机构调研记录】德邦基金调研爱博医疗
【私募调研记录】中欧瑞博调研爱博医疗
证券之星 · 2025-11-05
【私募调研记录】中欧瑞博调研爱博医疗
每周股票复盘：爱博医疗（688050）Q3净利降29.85%，股东户数增11.72%
证券之星 · 2025-11-02
每周股票复盘：爱博医疗（688050）Q3净利降29.85%，股东户数增11.72%
爱博医疗(688050)9月30日股东户数1.72万户，较上期增加11.72%
证券之星 · 2025-10-30
爱博医疗(688050)9月30日股东户数1.72万户，较上期增加11.72%
图解爱博医疗三季报：第三季度单季净利润同比下降29.85%
证券之星 · 2025-10-30
图解爱博医疗三季报：第三季度单季净利润同比下降29.85%
公募再成定增大户！今年来300亿公募资金入局定增 浮盈超百亿
智通财经网 · 2025-10-24
公募再成定增大户！今年来300亿公募资金入局定增 浮盈超百亿
爱博医疗(688050.SH)：焦深延长型人工晶状体通过创新医疗器械特别审查程序获批上市
智通财经 · 2025-09-26
爱博医疗(688050.SH)：焦深延长型人工晶状体通过创新医疗器械特别审查程序获批上市
每周股票复盘：爱博医疗（688050）营收增14.72%，净利增2.53%
证券之星 · 2025-09-21
每周股票复盘：爱博医疗（688050）营收增14.72%，净利增2.53%
每周股票复盘：爱博医疗（688050）现201.02万元大宗交易
证券之星 · 2025-09-14
每周股票复盘：爱博医疗（688050）现201.02万元大宗交易
爱博医疗：现有产品未涉及脑机接口领域
市场资讯 · 2025-09-11
爱博医疗：现有产品未涉及脑机接口领域
30余股评级获上调！红利、科技受青睐，这类股评级遭下调
券商中国 · 2025-09-10
30余股评级获上调！红利、科技受青睐，这类股评级遭下调
9月9日爱博医疗现201.02万元大宗交易
证券之星 · 2025-09-09
9月9日爱博医疗现201.02万元大宗交易
每周股票复盘：爱博医疗（688050）9月首周现42笔大宗交易机构净买入超亿元
证券之星 · 2025-09-07
每周股票复盘：爱博医疗（688050）9月首周现42笔大宗交易机构净买入超亿元
华安证券：给予爱博医疗买入评级
证券之星 · 2025-09-04
华安证券：给予爱博医疗买入评级
加载更多
公司概况
公司名称：
爱博诺德(北京)医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-07-29
主营业务：
爱博诺德(北京)医疗科技股份有限公司的主营业务是眼科医疗器械的自主研发、生产、销售及相关服务。公司的主要产品是眼科医疗器械及相关服务。
发行价格：
33.55
{"stockData":{"symbol":"688050","market":"SH","secType":"STK","nameCN":"爱博医疗","latestPrice":59.88,"timestamp":1770102000000,"preClose":59.53,"halted":0,"volume":2063270,"delay":0,"changeRate":0.0059,"floatShares":193000000,"shares":193000000,"eps":1.8665,"marketStatus":"已收盘","change":0.35,"latestTime":"02-03 15:00:00","open":59.6,"high":60.26,"low":59.55,"amount":124000000,"amplitude":0.0119,"askPrice":59.89,"askSize":45,"bidPrice":59.88,"bidSize":54,"shortable":0,"etf":0,"ttmEps":1.8665,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770168600000},"marketStatusCode":5,"adr":0,"adjPreClose":59.53,"symbolType":"stock_kcb","openAndCloseTimeList":[[1770082200000,1770089400000],[1770094800000,1770102000000]],"highLimit":65.48,"lowLimit":53.58,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":193403175,"isCdr":false,"pbRate":4.12,"roa":"--","peRate":32.081436,"roe":"10.96%","epsLYR":2.05,"committee":0.446494,"marketValue":11581000000,"turnoverRate":0.0107,"status":0,"afterMarket":{"amount":0,"volume":0,"close":59.88,"buyVolume":0,"sellVolume":0,"time":1770104037558,"indexStatus":"已收盘 02-03 15:30:00","preClose":59.53},"floatMarketCap":11581000000},"requestUrl":"/m/hq/s/688050","defaultTab":"news","newsList":[{"id":"2605466672","title":"10亿跨界并购背后：爱博医疗的增长焦虑与整合难题","url":"https://stock-news.laohu8.com/highlight/detail?id=2605466672","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605466672?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:36","pubTimestamp":1769070960,"startTime":"0","endTime":"0","summary":"眼科龙头爱博医疗正试图通过一场跨界并购，寻找新的增长故事。近日，公司宣布拟以不超过10亿元估值收购运动医学企业德美医疗不低于51%股权，切入以关节与肌肉为核心的运动医学赛道。然而，在主业增长乏力、股价持续低迷的背景下，这场并购能否真正带来协同效应，仍面临估值、对赌与整合三重考验。 对爱博医疗而言，这场跨界并购既是寻找第二增长曲线的战略尝试，也是一场充满变数的赌博。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-22/doc-inhiepsr4563589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688050","LU2460026573.USD","BK0251"],"gpt_icon":0},{"id":"2604415115","title":"爱博医疗(688050.SH)拟收购德美医疗不低于51%股权 拓宽医疗健康领域布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2604415115","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604415115?lang=zh_cn&edition=full","pubTime":"2026-01-20 21:26","pubTimestamp":1768915610,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱博医疗 发布公告，公司于2026年1月20日与德美联合(重庆)医疗科技有限公司及德美医疗创始人、第一大股东、董事长、总经理兼法定代表人黎建波签署《投资意向书》，公司拟通过并购贷款及自有资金出资方式收购标的公司不低于51%的股权并取得标的公司的控制权。通过本次收购标的公司控股权，公司拓宽医疗健康领域布局，在研发、生产制造、销售渠道等方面与标的公司协同，进一步提升公司业绩与股东回报水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLV","159760","159891","LU2460026573.USD","688050","BK4585","XBI","BK4581","LABU","BK0251","BK4588"],"gpt_icon":0},{"id":"2585106969","title":"每周股票复盘：爱博医疗（688050）将召开2025年Q3业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585106969","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585106969?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:46","pubTimestamp":1763844371,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，爱博医疗报收于60.3元，较上周的64.83元下跌6.99%。本周，爱博医疗11月17日盘中最高价报65.0元。11月21日盘中最低价报59.63元，股价触及近一年最低点。爱博医疗当前最新总市值116.62亿元，在医疗器械板块市值排名25/126，在两市A股市值排名1552/5167。投资者可于2025年11月21日至11月27日16:00前通过上证路演中心或公司邮箱提交问题。说明会结束后可通过上证路演中心查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","BK0251","688050"],"gpt_icon":0},{"id":"2582316464","title":"爱博医疗（688050）359.36万股限售股将于11月12日解禁，占总股本1.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316464","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582316464?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:05","pubTimestamp":1762905924,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，爱博医疗于11月12日将有359.36万股限售股份解禁，为公司定向增发机构配售股份，占公司总股本1.86%。本次解禁后，公司已无限售股份。爱博医疗主营业务：专注于眼科医疗器械的自主研发、生产、销售及相关服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200005049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","688050","BK0251"],"gpt_icon":0},{"id":"2581718050","title":"爱博医疗目标价涨幅超70%，荣盛石化、珀莱雅评级被调低","url":"https://stock-news.laohu8.com/highlight/detail?id=2581718050","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581718050?lang=zh_cn&edition=full","pubTime":"2025-11-05 10:32","pubTimestamp":1762309920,"startTime":"0","endTime":"0","summary":"南财投研通数据显示，11月4日，券商给予上市公司目标价共67次，按最新收盘价计算，目标价涨幅排名居前的公司有爱博医疗、凌云股份、豪悦护理，目标价涨幅分别为70.94%、54.33%、51.42%，分 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20251105/c672255919.shtml","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251105/c672255919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["002493","688050","603605"],"gpt_icon":0},{"id":"2581799450","title":"【机构调研记录】格林基金调研潮宏基、爱博医疗等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2581799450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581799450?lang=zh_cn&edition=full","pubTime":"2025-11-05 08:06","pubTimestamp":1762301189,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月4日披露的机构调研信息，格林基金近期对3家上市公司进行了调研，相关名单如下：1）潮宏基 调研纪要：公司通过产品创新、运营能力提升及加盟扩张推动收入增长与盈利能力改善。3）心脉医疗 调研纪要：2025年第三季度，公司实现营业收入3亿元、归母净利润1.14亿元，剔除政府补贴及其他投资收益影响后净利润同比增长60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500005019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050","BK0127","BK0251","BK0107","BK0262","LU2460026573.USD","BK0070","002345"],"gpt_icon":0},{"id":"2581799115","title":"【机构调研记录】德邦基金调研爱博医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2581799115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581799115?lang=zh_cn&edition=full","pubTime":"2025-11-05 08:06","pubTimestamp":1762301177,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月4日披露的机构调研信息，德邦基金近期对1家上市公司进行了调研，相关名单如下：1）爱博医疗 个股亮点：公司已自主开发普诺瞳 AI数字验配系统。德邦基金成立于2012年，截至目前，资产管理规模605.16亿元，排名81/211；资产管理规模494.4亿元，排名77/211；管理公募基金数70只，排名84/211；旗下公募基金经理16人，排名84/211。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500005005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","688050","BK0251"],"gpt_icon":0},{"id":"2581991227","title":"【私募调研记录】中欧瑞博调研爱博医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2581991227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581991227?lang=zh_cn&edition=full","pubTime":"2025-11-05 08:04","pubTimestamp":1762301095,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月4日披露的机构调研信息，知名私募中欧瑞博近期对1家上市公司进行了调研，相关名单如下：1）爱博医疗 个股亮点：公司已自主开发普诺瞳 AI数字验配系统。机构简介：深圳市中欧瑞博投资管理股份有限公司于2007年成立，是中国最早的私募基金管理公司之一。取名\"兔子基金\"体现了中欧瑞博敬畏风险的投资文化，并始终把风险防范和管理摆在突出位置。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025110500004929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","BK0251","688050"],"gpt_icon":0},{"id":"2580036204","title":"每周股票复盘：爱博医疗（688050）Q3净利降29.85%，股东户数增11.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580036204","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580036204?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:33","pubTimestamp":1762047190,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，爱博医疗报收于64.84元，较上周的70.48元下跌8.0%。股本股东变化截至2025年9月30日，公司股东户数为1.72万户，较6月30日增加1806户，增幅11.72%。第三季度单季主营收入3.58亿元，同比下降8.17%；归母净利润7684.86万元，同比下降29.85%；扣非净利润7532.46万元，同比下降28.47%。利润总额同比减少10.90%，主要因人工晶状体受集采影响及隐形眼镜市场竞争加剧导致收入与利润率下滑。报告期末普通股股东总数为17,214户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","688050","BK0251"],"gpt_icon":0},{"id":"2579600118","title":"爱博医疗(688050)9月30日股东户数1.72万户，较上期增加11.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579600118","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579600118?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:26","pubTimestamp":1761816419,"startTime":"0","endTime":"0","summary":"证券之星消息，近日爱博医疗披露，截至2025年9月30日公司股东户数为1.72万户，较6月30日增加1806.0户，增幅为11.72%。在医疗器械行业个股中，爱博医疗股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年6月30日至2025年9月30日，爱博医疗区间涨幅为8.62%，在此期间股东户数增加1806.0户，增幅为11.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2460026573.USD","688050"],"gpt_icon":0},{"id":"2579187938","title":"图解爱博医疗三季报：第三季度单季净利润同比下降29.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579187938","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579187938?lang=zh_cn&edition=full","pubTime":"2025-10-30 02:55","pubTimestamp":1761764149,"startTime":"0","endTime":"0","summary":"证券之星消息，爱博医疗2025年三季报显示，前三季度公司主营收入11.44亿元，同比上升6.43%；归母净利润2.9亿元，同比下降8.64%；扣非净利润2.8亿元，同比下降8.14%；其中2025年第三季度，公司单季度主营收入3.58亿元，同比下降8.17%；单季度归母净利润7684.86万元，同比下降29.85%；单季度扣非净利润7532.46万元，同比下降28.47%；负债率22.93%，投资收益381.86万元，财务费用1387.66万元，毛利率64.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000002939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050"],"gpt_icon":0},{"id":"2577557959","title":"公募再成定增大户！今年来300亿公募资金入局定增 浮盈超百亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2577557959","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577557959?lang=zh_cn&edition=full","pubTime":"2025-10-24 10:29","pubTimestamp":1761272947,"startTime":"0","endTime":"0","summary":"公募年内定增超300亿元，浮盈超百亿元；有色、化工、机械设备浮盈比例领先；诺德、财通等机构参与规模与收益突出","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251024/20251024102927_84195.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251024/20251024102927_84195.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1781817850.SGD","SG9999006597.SGD","BK0251","BK0126","300476","LU1580142542.USD","SG9999003461.SGD","BK0214","000100","688256","SGXZ90724238.SGD","BK0226","BK0196","LU0469268626.HKD","BK0197","605300","688050","LU2460026573.USD","SGXZ81163826.USD","688082","BK0188","BK0030","LU1808992512.USD","SG9999001093.SGD","SG9999001051.SGD","BK0028","BK0152","BK0045","LU2778985437.USD","LU1934453819.USD","BK0012","SG9999001069.SGD","LU2476274308.USD","SG9999002950.SGD","LU1979443071.USD","LU2476274720.SGD","BK0026","BK0231","SGXZ49509284.SGD","BK0086"],"gpt_icon":0},{"id":"2570080470","title":"爱博医疗(688050.SH)：焦深延长型人工晶状体通过创新医疗器械特别审查程序获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2570080470","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570080470?lang=zh_cn&edition=full","pubTime":"2025-09-26 16:32","pubTimestamp":1758875539,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱博医疗(688050.SH)发布公告，公司“焦深延长型人工晶状体”于近日通过国家药品监督管理局创新医疗器械特别审查获准注册。焦深延长型人工晶状体属于高端屈光性人工晶状体，该产品适用于成年人白内障摘除手术后无晶状体眼的视力矫正，通过高次非球面设计实现人眼焦深延长，在不显著降低远视力的前提下改善中视力，降低对眼镜的依赖程度。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","09997","BK1583","LU2460026573.USD","159883","688050","BK1100","BK1222","BK1574","09996"],"gpt_icon":0},{"id":"2569246654","title":"每周股票复盘：爱博医疗（688050）营收增14.72%，净利增2.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246654","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246654?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:14","pubTimestamp":1758399254,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，爱博医疗报收于75.6元，较上周的78.27元下跌3.41%。本周，爱博医疗9月15日盘中最高价报78.6元。报告期内，公司营业收入7.87亿元，同比增长14.72%；归属于上市公司股东的净利润2.13亿元，同比增长2.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050"],"gpt_icon":0},{"id":"2567133941","title":"每周股票复盘：爱博医疗（688050）现201.02万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2567133941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567133941?lang=zh_cn&edition=full","pubTime":"2025-09-14 02:28","pubTimestamp":1757788094,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，爱博医疗（688050）报收于78.27元，较上周的78.98元下跌0.9%。本周，爱博医疗9月8日盘中最高价报83.83元。9月11日盘中最低价报77.7元。爱博医疗当前最新总市值152.31亿元，在医疗器械板块市值排名21/126，在两市A股市值排名1252/5153。本周关注点交易信息汇总：9月9日爱博医疗现201.02万元大宗交易交易信息汇总9月9日爱博医疗现201.02万元大宗交易以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688050","BK0251","LU2460026573.USD"],"gpt_icon":0},{"id":"2566196506","title":"爱博医疗：现有产品未涉及脑机接口领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2566196506","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566196506?lang=zh_cn&edition=full","pubTime":"2025-09-11 17:21","pubTimestamp":1757582511,"startTime":"0","endTime":"0","summary":"有投资者在互动平台向爱博医疗提问：“您好董秘，贵司产品是否可应用于脑机接口领域？是否有相关技术的研发和储备？”针对上述提问，爱博医疗回应称：“尊敬的投资者，您好！公司现有产品未涉及脑机接口领域。关于在研产品的具体进展，敬请关注公司定期报告和临时公告。感谢您对爱博医疗的关注！”声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。\n\n\r\n 责任编辑：钟离","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/11172153072882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2460026573.USD","688050","BK0251"],"gpt_icon":0},{"id":"2566989457","title":"30余股评级获上调！红利、科技受青睐，这类股评级遭下调","url":"https://stock-news.laohu8.com/highlight/detail?id=2566989457","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566989457?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:19","pubTimestamp":1757510340,"startTime":"0","endTime":"0","summary":"与此同时，分析师也在结合最新财报数据调整股票评级，近期30余股被上调评级，主要集中在红利、科技等板块；同时有20余股评级遭下调，尤其白酒股是重灾区。券商上调30余股评级，高股息、科创赛道受关注近半个月，券商分析师也在半年报集中披露后密集调整股票评级。在医药生物领域也有部分个股被券商下调评级，一些券商出于股票前期涨幅较大适当调低评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3NjM5MjIwOQ==&mid=2652234412&idx=2&sn=a1e0f54999d20fa128894eb13a3f08f7&chksm=856ff3ef362ce1b0fd1c64c6e723ec23f7a00d80db35a9a2e7a63767bff9679ee5121203504d&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["000969","688008","LU1064130708.USD","LU1430594728.SGD","600779","688019","IE00B031J352.USD","002738","600199","LU1808992512.USD","002219","688676","000596","300953","002487","300395","600795","605555","603662","603919","002518","688050","LU0605514214.HKD","603501","688363","603690","600025","601838","600761","688097","688351","688428","600900","002851","LU0320764599.SGD","LU1997245094.SGD","LU2348774022.SGD","SG9999003461.SGD","LU0405327148.USD","LU0890818403.SGD","LU2495084118.USD","688235","002171","000858","LU1720050803.USD","300870","002916","601825","300760"],"gpt_icon":1},{"id":"2566169822","title":"9月9日爱博医疗现201.02万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2566169822","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566169822?lang=zh_cn&edition=full","pubTime":"2025-09-09 17:21","pubTimestamp":1757409669,"startTime":"0","endTime":"0","summary":"证券之星消息，9月9日爱博医疗发生大宗交易，交易数据如下：大宗交易成交价格79.77元，成交2.52万股，成交金额201.02万元，买方营业部为中信证券股份有限公司上海分公司，卖方营业部为中信证券华南股份有限公司佛山分公司。近三个月该股共发生64笔大宗交易，合计成交4.02万手，折价成交62笔，溢价成交1笔。截至2025年9月9日收盘，爱博医疗报收于79.77元，下跌3.19%，换手率3.11%，成交量5.9万手，成交额4.74亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900027960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","688050","BK0251"],"gpt_icon":0},{"id":"2565254510","title":"每周股票复盘：爱博医疗（688050）9月首周现42笔大宗交易机构净买入超亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565254510","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565254510?lang=zh_cn&edition=full","pubTime":"2025-09-07 02:57","pubTimestamp":1757185029,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，爱博医疗报收于78.98元，较上周的77.81元上涨1.5%。本周，爱博医疗9月2日盘中最高价报82.1元。本周关注点交易信息汇总：9月1日至3日爱博医疗共发生42笔大宗交易，机构合计净买入超1.1亿元。交易信息汇总9月3日爱博医疗发生18笔大宗交易，机构净买入5556.44万元。股本股东变化9月4日爱博医疗公告，股东白莹于2025年8月7日至9月3日期间合计减持215.87万股，占公司总股本的1.1162%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","BK0251","688050"],"gpt_icon":0},{"id":"2564347149","title":"华安证券：给予爱博医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2564347149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564347149?lang=zh_cn&edition=full","pubTime":"2025-09-04 12:11","pubTimestamp":1756959065,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李婵近期对爱博医疗进行研究并发布了研究报告《2025Q2业绩改善，利润增速回正》，给予爱博医疗买入评级。 爱博医疗 主要观点： 事件： 公司发布2025年中报。 角膜塑形镜：2025年上半年收入1.19亿元，同比增长5.63%，在竞争加剧和消费降级的形势下，公司仍保持了销量的持续增长。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级5家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400016187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","688050"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770135851360,"stockEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":-0.0129},{"period":"3month","weight":-0.057},{"period":"6month","weight":-0.2242},{"period":"1year","weight":-0.3651},{"period":"ytd","weight":-0.0129}],"compareEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":0.0249},{"period":"3month","weight":0.0248},{"period":"6month","weight":0.1176},{"period":"1year","weight":0.2514},{"period":"ytd","weight":0.0249}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱博诺德(北京)医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"17214人(较上一季度增加11.72%)","perCapita":"11235股","listingDate":"2020-07-29","address":"北京市昌平区科技园区兴昌路9号","registeredCapital":"19340万元","survey":" 爱博诺德(北京)医疗科技股份有限公司的主营业务是眼科医疗器械的自主研发、生产、销售及相关服务。公司的主要产品是眼科医疗器械及相关服务。","listedPrice":33.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱博医疗(688050)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱博医疗(688050)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱博医疗,688050,爱博医疗股票,爱博医疗股票老虎,爱博医疗股票老虎国际,爱博医疗行情,爱博医疗股票行情,爱博医疗股价,爱博医疗股市,爱博医疗股票价格,爱博医疗股票交易,爱博医疗股票购买,爱博医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱博医疗(688050)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱博医疗(688050)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}